BCG immunotherapy for bladder cancer triggers systemic and local BCG-specific CD4+ Th1 responses.

Saved in:
Bibliographic Details
Title: BCG immunotherapy for bladder cancer triggers systemic and local BCG-specific CD4+ Th1 responses.
Authors: Rollin P; Institut de Recherche Saint-Louis, Université Paris-Cité, Inserm U1342, Paris, France.; Department of Urology, Bichat-Claude Bernard Hospital, Assistance-Publique Hôpitaux de Paris, Université Paris-Cité, Paris, France.; Department of Urology, Saint-Louis Hospital, Assistance-Publique Hôpitaux de Paris, Paris, France., Pluskwa B; Institut de Recherche Saint-Louis, Université Paris-Cité, Inserm U1342, Paris, France., Artru E; Institut de Recherche Saint-Louis, Université Paris-Cité, Inserm U1342, Paris, France., Le Vaslot T; Institut de Recherche Saint-Louis, Université Paris-Cité, Inserm U1342, Paris, France., Kartasheva-Ebertz D; Institut de Recherche Saint-Louis, Université Paris-Cité, Inserm U1342, Paris, France., Biron D; Institut de Recherche Saint-Louis, Université Paris-Cité, Inserm U1342, Paris, France., Bossis M; Institut de Recherche Saint-Louis, Université Paris-Cité, Inserm U1342, Paris, France., Onodi F; Institut de Recherche Saint-Louis, Université Paris-Cité, Inserm U1342, Paris, France., LeMaoult J; Institut de Recherche Saint-Louis, Université Paris-Cité, Inserm U1342, Paris, France.; Hemato-Immunology Research Department, CEA, DRF-François Jacob Institute, Saint-Louis Hospital, Paris, France., Rouas-Freiss N; Institut de Recherche Saint-Louis, Université Paris-Cité, Inserm U1342, Paris, France.; Hemato-Immunology Research Department, CEA, DRF-François Jacob Institute, Saint-Louis Hospital, Paris, France., Chevalier MF; Institut de Recherche Saint-Louis, Université Paris-Cité, Inserm U1342, Paris, France., Lindestam Arlehamn CS; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, San Diego, CA, USA.; Center for Vaccine Research, Department of Infectious Disease Immunology, Statens Serum Institut, Copenhagen, Denmark., Sette A; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, San Diego, CA, USA.; Department of Medicine, University of California, San Diego, San Diego, CA, USA., Masson-Lecomte A; Institut de Recherche Saint-Louis, Université Paris-Cité, Inserm U1342, Paris, France.; Department of Urology, Saint-Louis Hospital, Assistance-Publique Hôpitaux de Paris, Paris, France.; Hemato-Immunology Research Department, CEA, DRF-François Jacob Institute, Saint-Louis Hospital, Paris, France., Desgrandchamps F; Institut de Recherche Saint-Louis, Université Paris-Cité, Inserm U1342, Paris, France.; Department of Urology, Saint-Louis Hospital, Assistance-Publique Hôpitaux de Paris, Paris, France.; Hemato-Immunology Research Department, CEA, DRF-François Jacob Institute, Saint-Louis Hospital, Paris, France., Xylinas E; Institut de Recherche Saint-Louis, Université Paris-Cité, Inserm U1342, Paris, France.; Department of Urology, Bichat-Claude Bernard Hospital, Assistance-Publique Hôpitaux de Paris, Université Paris-Cité, Paris, France., Tonnerre P; Institut de Recherche Saint-Louis, Université Paris-Cité, Inserm U1342, Paris, France.
Source: IScience [iScience] 2026 Jan 12; Vol. 29 (2), pp. 114676. Date of Electronic Publication: 2026 Jan 12 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101724038 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-0042 (Electronic) Linking ISSN: 25890042 NLM ISO Abbreviation: iScience Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2589-0042
DOI:10.1016/j.isci.2026.114676